INOVIQ

IIQ.AX

Tags: AU Healthcare Medical - Diagnostics & Research

INOVIQ Ltd Price (IIQ.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

92,424,440

(0.4409)%

Market Cap of INOVIQ (IIQ.AX)

Market cap:

As of , IIQ.AX has a market cap of . This makes IIQ.AX the 811th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BAR... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.345-0.8
Market Cap 41.26M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S.
IPO Date: January, 28, 1988
Country: AU
Currency: AUD
Headquaters: Notting Hill, VIC
Employees: 15

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: